Publication Chronology
1. Sheehan KM, DeLott LB, West RA, Bonnema JD, DeHeer DH. Hyaluronic acid of high molecular weight inhibits proliferation and induces cell death in U937 macrophage cells. Life Sci. 2004:75;26:3087-3102.
To read this abstract click here.
2. Mageed AS, Pietryga DW, DeHeer DH, West RA. Isolation of Large Numbers of Mesenchymal Stem Cells from the Washings of Bone Marrow Collection Bags: Characterization of Fresh Mesenchymal Stem Cells. Transplantation. 2007:83(8);1019-1026.
To read this abstract click here.
3. Kathryn M. Eisenmann, Richard A. West, Dagmar Hildebrand, Susan M. Kitchen, Jun Peng, Robert Sigler, Jinyi Zhang, Katherine A. Siminovitch, and Arthur S. Alberts. 2007. T cell responses in mammalian diaphanous-related formin mDia1 knockout mice. Journal of Biological Chemistry 282(34): 25152-25158.
To read this abstract click here.
4. Peng J, Susan M. Kitchen, Richard A. West, Robert Sigler, Kathryn M. Eisenmann, and Arthur S. Alberts. 2007. Myeloproliferative Defects Following Targeting of the Drf1 Gene Encoding the Mammalian Diaphanous-related Formin mDia1. Cancer Research 67(16): 7565-7571.
To read this abstract click here.
5. Knudsen BS, Zhao P, Resau J, Cottingham S, Gherardi E, Xu E, Resau J, Berghuis B, Daugherty J, Grabinski T, Toro J, Giambernardi T, Skinner RS, Gross M, Hudson E, Kort E, Lengyel E, Ventura A, West RA, Xie Q, Hay R, Woude GV, Cao B. A Novel Multipurpose Monoclonal Antibody for Evaluating Human c-Met Expression in Preclinical and Clinical Settings. Appl Immunohistochem Mol Morphol. 2009 Jan;17(1):57-67.
To read this abstract click here.
6. Lindvall C, Zylstra CR, Evans N, West RA, Dykema K, Furge KA and Williams BO. The Wnt Co-Receptor Lrp6 is Required for Normal Mouse Mammary Development. PLoS ONE. 2009 Jun 5;4(6):e5813.
To read this abstract click here.
7. Eisenmann KM, Dykema KJ, Matheson SF, Kent NF, DeWaard AD, West RA, Tibes R, Furge KA, Alberts AS. 5q- Myelodysplastic Syndromes: Chromosome 5q Genes Direct a Tumor-suppression Network Sensing Actin Dynamics. Oncogene 2009 Oct 1;28(39):3429-41. Epub 2009
Jul 13.
To read this abstract click here.
8. DeWard, A.D., K. Leali, R. West, G.C. Prendergast, and A.S. Alberts. Loss of RhoB Expression Enhances the Myelodysplastic Phenotype of mammalian Diaphanous-related Formin mDia1 Knockout Mice. PLoS One. 2009 Sep 21;4(9):e7102.PMID: 19768111.
To read this abstract click here.
9. Harris CA, Resau JH, Hudson EA, West RA, Moon C, McAllister JP. Mechanical Contributions to Astrocyte Adhesion Using a Novel in vitro Model of Catherter Obstruction. Exp Neurol. 2010 Apr;222(2):204-10. PMID: 20051241.
To read this abstract click here.
10. Zhang YW, Staal B, Essenburg C, Su Y, Kang L, West RA, Kaufman D, Dekoning T, Eagleson B, Buchanan SG, Vande Woude GF. MET Kinase Inhibitor SGX523 Synergizes with EGFR Inhibitor Erlotonib in an HGF-Dependent Fashion to Suppress Carcinoma Growth. Cancer Res. 2010 Jul 19. ePub ahead of print. PMID: 20643778.
To read this abstract click here.
11. Harris CA, Resau JH, Hudson EA, West RA, Moon C, Black AD, McAllister JP 2nd. Effects of surface wettability, flow, and protein concentration on macrophage and astrocyte adhesion in an in vitro model of central nervous system catheter obstruction. J Biomed Mater Res A. 2011 Jun 15;97(4):433-40. doi: 10.1002/jbm.a.33078. Epub 2011 Apr 11. PMID: 21484987
To read this abstract click here.
12. Harris CA, Resau JH, Hudson EA, West RA, Moon C, Black AD, McAllister JP 2nd. Reduction of protein adsorption and macrophage and astrocyte adhesion on ventricular catheters by polyethylene glycol and N-acetyl-L-cysteine. J Biomed Mater Res A. 2011 May 31. doi: 10.1002/jbm.a.33130. [Epub ahead of print]. PMID: 21630435
To read this abstract click here.
13. Turovets N, Fair J, West R, Ostrowska A, Semechkin R, Janus J, Cui L, Agapov V, Turovets I, Semechkin A, Csete M, Agapova L. Derivation of High Purity Definitive Endoderm from Human Parthenogenic Stem Cells Using and in vitro Analog of the Primitive Streak. Cell Transplant. 2011 Jun 9. [epub ahead of print] PMID: 21669044
To read this abstract click here.
14. Isaev DA, Garitaonandia I, Abramihina TV, Zogovic-Kapsalis T, West RA, Semechkin AY, Muller AM, Semechkin RA. In vitro Differentiation of Human Parthenogenetic Stem Cells Into Neural Lineages. Regen Med. 2012 Jan;7(1):37-45. PMID: 22168496
To read this abstract click here.
15. Duggan J, Okonta H, Elnaggar D, French J,West R, Chakraborty J. Retrovirus induced lymphomagenesis - A correlation between disease pathogenesis and flow cytometric analysis. J Gen Virol. 2012 Jun 6. [Epub ahead of print] PMID: 22673934
To read this abstract click here.
Acknowledgements
Select publications that acknowledge the owner and staff for significant contributions.
1. Warzynski MJ, Graham DM, Axtell RA, Higgins JV, Hammers YA. Flow cytometric immunophenotyping test for staging/monitoring Neuroblastoma patients. Cytometry. 2002 Dec 15;50(6):298-304
2. Freyer DR, Gowans LK, Warzynski M, Lee WI. Flow cytometric diagnosis of X-linked hyper-IgM syndrome: application of an accurate and convenient procedure. J Pediatr Hematol Oncol. 2004 Jun;26(6):363-70
3. Edick MJ, Lamb LE, Knudsen BS, Miranti CK. Inhibition of integrin-mediated crosstalk with epidermal growth factor receptor/Erk or Src signaling pathways in autophagic prostate epithelial cells induces caspase-independent death. Mol Biol Cell. 2007 Jul;18(7):2481-90. Epub 2007 May 2
4. Wang X, Zhu J, Zhao P, Jiao Y, Xu N, Grabinski T, Liu C, Miranti CK, Fu T, Cao BB. In vitro efficacy of immuno-chemotherapy with anti-EGFR human Fab-Taxol conjugate on A431 epidermoid carcinoma cells. Cancer Biol Ther. 2007 Jun;6(6):980-7. Epub 2007 Mar 26
5. Zhao P. Grabinski T, Gao C, Skinner RS, Giambernardi T, Su Y, Hudson E, Resau J, Gross M, Vande Woude GF, Hay R, Cao B. Identification of a met-binding peptide from a phage display library. Clin Cancer Res. 2007 Oct 15;13(20):6049-55
6. Huang D, Ding Y, Luo WM, Bender S, Qian CN, Kort E, Zhang ZF, VandenBeldt K, Duesbery NS, Resau JH, The B. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo. Cancer Res. 2008 Jan 1;68(1):81-8. doi: 10.1158/0008-5472.CAN-07-5311
7. Chen J, Futami K, Petillo D, Peng J, Wang P, Knol J, Li Y, Khoo SK, Huang D, Qian CN, Zhao P, Dykema K, Zhang R, Cao B, Yang XJ, Furge K, Williams BO, The BT. Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. PLoS One. 2008;3(10):e3581. doi: 10.1371/journal.pone.0003581. Epub 2008 Oct 30
8. Abdel-Mageed AS, Senagore AJ, Pietryga DW, Connors RH, Giambernardi TA, Hay RV, Deng W. Intravenous administration of mesenchymal stem cells genetically modified with extracellular superoxide dismutase improves survival in irradiated mice. Blood. 2009 Jan 29;113(5):1201-3. doi: 10.1182/blood-2008-07-170936
9. Vanbrocklin MW, Robinson JP, Whitwam T, Guilbeault AR, Koeman J, Swiatek P, Vande Woude GF, Khoury JD, Holmen SL. Met amplification and tumor progression in Cdkn2a-deficient melanocytes. Pigment Cell Melanoma Res. 2009 Aug;22(4):454-60. doi: 10.1111/j.1755-148X.2009.00576.x. Epub 2009 Apr 29
10. Bromberg-White JL, Boguslawski E, Duesbery NS. Perturbation of mouse retinal vascular morphogenesis by anthrax lethal toxin. PLoS One. 2009 Sep 14;4(9):e6956. doi: 10.1371/journal.pone.0006956
11. Lamb LE, Knudsen BS, Miranti CK. E-cadherin-mediated survival of androgen-receptor-expressing secretory prostate epithelial cells derived from a stratified in vitro differentiation model. J Cell Sci. 2010 Jan 15;123(Pt 2):266-76. doi: 10.1242/jcs.054502
12. Looyenga BD, Furge KA, Dykema KJ, Koeman J, Swiatek PJ, Giordano TJ, West AB, Resau JH, The BT, MacKeigan JP. Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas. Proc Natl Acad Sci USA. 2011 Jan 25;108(4):1439-44. doi: 10.1073/pnas.1012500108. Epub 2011 Jan 10
13. Looyenga BD, Furge KA, Dykema KJ, Koeman J, Swiatek PJ, Giordano TJ, West AB, Resau JH, The BT, MacKeigan JP. Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas. Proc Natl Acad Sci USA. 2011 Jan 25;108(4):1439-44. doi: 10.1073/pnas.1012500108. Epub 2011 Jan 10
14. Lamb E, Zarif JC, Miranti CK. The androgen receptor induces integrin _6_1 to promote prostate tumor cell survival via NF-_B and Bcl-xL Independently of PI3K signaling. Cancer Res. 2011 Apr 1;71(7):2739-49. doi: 10.1158/0008-5472.CAN-10-2745. Epub 2011 Feb 10
15. Lee CS, Dykema KJ, Hawkins DM, Cherba DM, Webb CP, Furge KA, Duesbery NS. MEK2 is sufficient but not necessary for proliferation and anchorage-independent growth of SK-MEL-28 melanoma cells. PLoS One. 2011 Feb 18;6(2):e17165. doi: 10.1371/journal.pone.0017165
16. Edwards TG, Helmus MJ, Koeller K, Bashkin JK, Fisher C. Human papillomavirus episome stability is reduced by aphidicolin and controlled by DNA damage response pathways. J Virol. 2013 Apr;87(7):3979-89. doi: 10.1128/JVI.03473-12. Epub 2013 Jan 30
1. Warzynski MJ, Graham DM, Axtell RA, Higgins JV, Hammers YA. Flow cytometric immunophenotyping test for staging/monitoring Neuroblastoma patients. Cytometry. 2002 Dec 15;50(6):298-304
2. Freyer DR, Gowans LK, Warzynski M, Lee WI. Flow cytometric diagnosis of X-linked hyper-IgM syndrome: application of an accurate and convenient procedure. J Pediatr Hematol Oncol. 2004 Jun;26(6):363-70
3. Edick MJ, Lamb LE, Knudsen BS, Miranti CK. Inhibition of integrin-mediated crosstalk with epidermal growth factor receptor/Erk or Src signaling pathways in autophagic prostate epithelial cells induces caspase-independent death. Mol Biol Cell. 2007 Jul;18(7):2481-90. Epub 2007 May 2
4. Wang X, Zhu J, Zhao P, Jiao Y, Xu N, Grabinski T, Liu C, Miranti CK, Fu T, Cao BB. In vitro efficacy of immuno-chemotherapy with anti-EGFR human Fab-Taxol conjugate on A431 epidermoid carcinoma cells. Cancer Biol Ther. 2007 Jun;6(6):980-7. Epub 2007 Mar 26
5. Zhao P. Grabinski T, Gao C, Skinner RS, Giambernardi T, Su Y, Hudson E, Resau J, Gross M, Vande Woude GF, Hay R, Cao B. Identification of a met-binding peptide from a phage display library. Clin Cancer Res. 2007 Oct 15;13(20):6049-55
6. Huang D, Ding Y, Luo WM, Bender S, Qian CN, Kort E, Zhang ZF, VandenBeldt K, Duesbery NS, Resau JH, The B. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo. Cancer Res. 2008 Jan 1;68(1):81-8. doi: 10.1158/0008-5472.CAN-07-5311
7. Chen J, Futami K, Petillo D, Peng J, Wang P, Knol J, Li Y, Khoo SK, Huang D, Qian CN, Zhao P, Dykema K, Zhang R, Cao B, Yang XJ, Furge K, Williams BO, The BT. Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. PLoS One. 2008;3(10):e3581. doi: 10.1371/journal.pone.0003581. Epub 2008 Oct 30
8. Abdel-Mageed AS, Senagore AJ, Pietryga DW, Connors RH, Giambernardi TA, Hay RV, Deng W. Intravenous administration of mesenchymal stem cells genetically modified with extracellular superoxide dismutase improves survival in irradiated mice. Blood. 2009 Jan 29;113(5):1201-3. doi: 10.1182/blood-2008-07-170936
9. Vanbrocklin MW, Robinson JP, Whitwam T, Guilbeault AR, Koeman J, Swiatek P, Vande Woude GF, Khoury JD, Holmen SL. Met amplification and tumor progression in Cdkn2a-deficient melanocytes. Pigment Cell Melanoma Res. 2009 Aug;22(4):454-60. doi: 10.1111/j.1755-148X.2009.00576.x. Epub 2009 Apr 29
10. Bromberg-White JL, Boguslawski E, Duesbery NS. Perturbation of mouse retinal vascular morphogenesis by anthrax lethal toxin. PLoS One. 2009 Sep 14;4(9):e6956. doi: 10.1371/journal.pone.0006956
11. Lamb LE, Knudsen BS, Miranti CK. E-cadherin-mediated survival of androgen-receptor-expressing secretory prostate epithelial cells derived from a stratified in vitro differentiation model. J Cell Sci. 2010 Jan 15;123(Pt 2):266-76. doi: 10.1242/jcs.054502
12. Looyenga BD, Furge KA, Dykema KJ, Koeman J, Swiatek PJ, Giordano TJ, West AB, Resau JH, The BT, MacKeigan JP. Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas. Proc Natl Acad Sci USA. 2011 Jan 25;108(4):1439-44. doi: 10.1073/pnas.1012500108. Epub 2011 Jan 10
13. Looyenga BD, Furge KA, Dykema KJ, Koeman J, Swiatek PJ, Giordano TJ, West AB, Resau JH, The BT, MacKeigan JP. Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas. Proc Natl Acad Sci USA. 2011 Jan 25;108(4):1439-44. doi: 10.1073/pnas.1012500108. Epub 2011 Jan 10
14. Lamb E, Zarif JC, Miranti CK. The androgen receptor induces integrin _6_1 to promote prostate tumor cell survival via NF-_B and Bcl-xL Independently of PI3K signaling. Cancer Res. 2011 Apr 1;71(7):2739-49. doi: 10.1158/0008-5472.CAN-10-2745. Epub 2011 Feb 10
15. Lee CS, Dykema KJ, Hawkins DM, Cherba DM, Webb CP, Furge KA, Duesbery NS. MEK2 is sufficient but not necessary for proliferation and anchorage-independent growth of SK-MEL-28 melanoma cells. PLoS One. 2011 Feb 18;6(2):e17165. doi: 10.1371/journal.pone.0017165
16. Edwards TG, Helmus MJ, Koeller K, Bashkin JK, Fisher C. Human papillomavirus episome stability is reduced by aphidicolin and controlled by DNA damage response pathways. J Virol. 2013 Apr;87(7):3979-89. doi: 10.1128/JVI.03473-12. Epub 2013 Jan 30
